| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jean Lud Cadet | |
| Natascha Wilson | |||
| P2860 | cites work | A review of MRI findings in schizophrenia | Q24657354 |
| Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 | ||
| Long-term effects of exposure to cannabis | Q28303390 | ||
| The pharmacology of cannabinoid receptors and their ligands: an overview | Q28304279 | ||
| The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
| International Union of Pharmacology. XXVII. Classification of cannabinoid receptors | Q29616832 | ||
| Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction | Q30053550 | ||
| Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. | Q30493991 | ||
| MRI anatomy of schizophrenia. | Q30577334 | ||
| Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia | Q30994462 | ||
| An update on regional brain volume differences associated with mood disorders | Q31036543 | ||
| Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders | Q31106608 | ||
| Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents | Q31870786 | ||
| Cerebral hemodynamics and processing speed during category learning | Q33202645 | ||
| The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings | Q33206291 | ||
| Lateralization of cerebral hemodynamics during Wisconsin Card Sorting Test: a functional transcranial Doppler sonography study | Q33213979 | ||
| Effects of frequent marijuana use on memory-related regional cerebral blood flow | Q48658000 | ||
| Basal ganglia shape alterations in bipolar disorder | Q48666609 | ||
| Subgenual prefrontal cortex abnormalities in mood disorders | Q48725544 | ||
| Reasons for substance use in schizophrenia | Q48735768 | ||
| Cerebellar metabolic activation by delta-9-tetrahydrocannabinol in human brain: A study with positron emission tomography and 18F-2-Fluoro-2-deoxyglucose | Q48736678 | ||
| Schizophrenic syndromes and frontal lobe performance | Q48774771 | ||
| Visuospatial working memory in patients with schizophrenia | Q48823163 | ||
| Acute marijuana effects on rCBF and cognition: a PET study | Q49153494 | ||
| Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain. | Q50794265 | ||
| The effect of extreme marijuana use on the long-term course of bipolar I illness: a single case study. | Q50891135 | ||
| Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. | Q51053111 | ||
| Psychiatric symptoms in mentally ill chemical abusers. | Q51161217 | ||
| Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. | Q51894564 | ||
| Community survey of bipolar disorder in Canada: lifetime prevalence and illness characteristics. | Q51921091 | ||
| Specific alterations of cerebral hemodynamics during a planning task: a transcranial Doppler sonography study. | Q51939707 | ||
| The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. | Q51977899 | ||
| Adults seeking treatment for marijuana dependence: a comparison with cocaine-dependent treatment seekers. | Q51988671 | ||
| Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. | Q52023847 | ||
| Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. | Q52028800 | ||
| Memory impairment in schizophrenia: a meta-analysis. | Q52032094 | ||
| The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. | Q52042140 | ||
| Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. | Q52061180 | ||
| Intellectual impairment in adolescent psychosis. A controlled psychometric study. | Q52069856 | ||
| Quantitative neuroanatomy in schizophrenia. A controlled magnetic resonance imaging study. | Q52070074 | ||
| Marihuana use and psychiatric illness. | Q52120146 | ||
| Psychiatric effects of hashish. | Q52120337 | ||
| An analysis of the specificity and the syndromal correlates of verbal memory impairments in schizophrenia. | Q52139222 | ||
| Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. | Q52187770 | ||
| Neural substrates of faulty decision-making in abstinent marijuana users. | Q52287608 | ||
| Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. | Q52926271 | ||
| The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. | Q53260493 | ||
| Patterns of metabolic activity in the treatment of schizophrenia. | Q53784242 | ||
| Increased fronto-temporal perfusion in bipolar disorder | Q57531473 | ||
| Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics | Q60632346 | ||
| Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. | Q64996366 | ||
| Cannabis Psychosis and Paranoid Schizophrenia | Q67442286 | ||
| Regional cerebral blood flow after marijuana smoking | Q67494880 | ||
| Working memory | Q67746071 | ||
| Mortality in affective disorder | Q72152805 | ||
| A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder | Q74499308 | ||
| Cerebral blood flow velocity in acute schizophrenic patients. A transcranial Doppler ultrasonography study | Q74646407 | ||
| Treatment of comorbid affective and substance use disorders. Therapeutic potential of anticonvulsants | Q77082421 | ||
| Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania | Q79470954 | ||
| Cerebral hemodynamic response induced by the Tower of Hanoi puzzle and the Wisconsin Card Sorting test | Q33336504 | ||
| Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes | Q33586386 | ||
| Women with schizophrenia and co-occurring substance use disorders: an increased risk for violent victimization and HIV. | Q33765594 | ||
| Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans | Q33886277 | ||
| Substance abuse and cognitive functioning in schizophrenia. | Q33921874 | ||
| Abstinence symptoms during withdrawal from chronic marijuana use. | Q33928980 | ||
| Psychiatric effects of cannabis | Q33931259 | ||
| Dose-related neurocognitive effects of marijuana use. | Q33962455 | ||
| Increased anterior cingulate and caudate activity in bipolar mania | Q34091225 | ||
| Neuropsychological performance in long-term cannabis users | Q34092892 | ||
| Development and consequences of cannabis dependence | Q34157382 | ||
| Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. | Q34264101 | ||
| Neuropsychology of bipolar disorder. | Q34271220 | ||
| Effects of frequent marijuana use on brain tissue volume and composition | Q34507628 | ||
| Adverse effects of atypical antipsychotics : differential risk and clinical implications | Q34583643 | ||
| The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research | Q34750185 | ||
| Marijuana withdrawal syndrome in the animal model | Q34986723 | ||
| Clinical aspects of substance abuse in persons with schizophrenia | Q35084956 | ||
| Substance use and cognition in early psychosis | Q35101398 | ||
| Endocannabinoid signaling system and brain reward: emphasis on dopamine | Q36152336 | ||
| Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder | Q36162402 | ||
| Schizophrenia and suicide: systematic review of risk factors | Q36182528 | ||
| Cannabis use and misuse prevalence among people with psychosis | Q36274751 | ||
| The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids | Q36341688 | ||
| Neurological assessments of marijuana users. | Q36408791 | ||
| Effects of cannabinoids on hypothalamic and reproductive function. | Q36441217 | ||
| The cannabis withdrawal syndrome | Q36448206 | ||
| Cognitive compromise in bipolar disorder with chronic cannabis use: cause or consequence? | Q36453302 | ||
| Depressive symptoms in adolescents: associations with white matter volume and marijuana use | Q36500702 | ||
| DSM-V research agenda: substance abuse/psychosis comorbidity | Q36843687 | ||
| Clinical trials: bridging the gap between efficacy and effectiveness | Q36951762 | ||
| Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports | Q37920156 | ||
| Retrieval from semantic memory using meaningful and meaningless constructs by depressed, stable bipolar and manic patients | Q38483782 | ||
| Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders | Q39535640 | ||
| The current status of the dopamine hypothesis of schizophrenia | Q39577491 | ||
| Cognitive deficits and the neurobiology of schizophrenia. | Q40450297 | ||
| Psychiatric symptoms in cannabis users | Q40697005 | ||
| Cognitive deficits in schizophrenia. | Q40825764 | ||
| Biological studies in schizophrenia | Q41336650 | ||
| Do patients use marijuana as an antidepressant? | Q41478668 | ||
| Dopamine activation of endogenous cannabinoid signaling in dorsal striatum | Q41646203 | ||
| Antipsychotic drug use patterns and the cost of treating schizophrenia | Q41727088 | ||
| Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain | Q42451047 | ||
| Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 | ||
| Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients | Q43723165 | ||
| Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. | Q43873792 | ||
| Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels | Q43878259 | ||
| Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders | Q43969348 | ||
| A controlled study of 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia | Q44035645 | ||
| Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence | Q44240058 | ||
| Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 | ||
| Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism | Q44418544 | ||
| Neuropsychological assessment of monozygotic twins discordant for schizophrenia | Q44455966 | ||
| Testing hypotheses about the relationship between cannabis use and psychosis | Q44487800 | ||
| Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up | Q44537020 | ||
| Cannabis use and psychosis: a longitudinal population-based study. | Q44820509 | ||
| The Marijuana Treatment Project: rationale, design and participant characteristics | Q44891155 | ||
| Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder. | Q44972400 | ||
| Significance of cocaine history in schizophrenia | Q45179111 | ||
| Altered brain tissue composition in heavy marijuana users | Q45193430 | ||
| Cerebrovascular perfusion in marijuana users during a month of monitored abstinence | Q45256305 | ||
| Verbal memory deficits associated with major affective disorders: a comparison of unipolar and bipolar patients | Q45298566 | ||
| Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function | Q45832281 | ||
| Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. | Q45941324 | ||
| Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. | Q46782998 | ||
| Cognitive impairment in schizophrenia: its impact on social functioning | Q47591346 | ||
| Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease | Q48108841 | ||
| Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia | Q48257411 | ||
| Role of the endogenous cannabinoid system in the regulation of motor activity | Q48285177 | ||
| The functional neuroanatomy of brain cannabinoid receptors | Q48285221 | ||
| A study of the septum pellucidum and corpus callosum in schizophrenia with MR imaging | Q48437212 | ||
| Neuropsychological deficits associated with schizophrenic syndromes | Q48468634 | ||
| Blood Flow and Oxidative Metabolism of the Brain in Patients with Schizophrenia | Q48481782 | ||
| Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography | Q48493233 | ||
| Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs. | Q48496728 | ||
| Abnormal brain activity in prefrontal brain regions in abstinent marijuana users | Q48514884 | ||
| Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study | Q48561754 | ||
| Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation | Q48595167 | ||
| Long-term effects of frequent cannabis use on working memory and attention: an fMRI study | Q48625540 | ||
| P433 | issue | 4 | |
| P921 | main subject | psychosis | Q170082 |
| cannabis abuse | Q25531259 | ||
| P304 | page(s) | 309-319 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Journal of Addictive Diseases | Q15766326 |
| P1476 | title | Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review | |
| P478 | volume | 28 |
| Q21260309 | A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies |
| Q35982298 | Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways |
| Q37120179 | Integrated treatment of substance use and psychiatric disorders |
| Q48173016 | Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat. |
| Q33836364 | Predictors of alcohol and drug dependence |
| Q48058613 | Profiles Associated Respectively with Substance Dependence Only, Mental Disorders Only and Co-occurring Disorders |
| Q33992170 | Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin |
| Q35387756 | Treatment of substance abusing patients with comorbid psychiatric disorders |
| Q45271353 | Typology of individuals with substance dependence based on a Montreal longitudinal catchment area study |
Search more.